MAB1553
抗肌联蛋白抗体，克隆9B9
culture supernatant, clone 9B9, Chemicon®
别名:
Anti-CMD1G, Anti-CMPD4, Anti-EOMFC, Anti-HMERF, Anti-LGMD2J, Anti-LGMDR10, Anti-MYLK5, Anti-SALMY, Anti-TMD
产品名称
抗肌联蛋白抗体，克隆9B9, culture supernatant, clone 9B9, Chemicon®
biological source
mouse
conjugate
unconjugated
antibody form
culture supernatant
antibody product type
primary antibodies
clone
9B9, monoclonal
species reactivity
human
manufacturer/tradename
Chemicon®
technique(s)
immunohistochemistry: suitable
western blot: suitable
isotype
IgG1
NCBI accession no.
UniProt accession no.
shipped in
dry ice
target post-translational modification
unmodified
Quality Level
Gene Information
human ... TTN(7273)
Preparation Note
以未稀释的等分试样在-20°C下冷冻保存长达12 个月。应避免反复冻/融循环。
Legal Information
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
Application
免疫化学：未稀释至1：10
蛋白质印迹：1:10-1:20
最佳稀释度必须由最终用户确定。
蛋白质印迹：1:10-1:20
最佳稀释度必须由最终用户确定。
研究子类别
细胞骨架
细胞骨架
研究类别
细胞结构
细胞结构
该抗肌联蛋白抗体克隆9B9已验证可用于 WB、IH中的肌联蛋白检测。
Biochem/physiol Actions
人骨骼肌肌联蛋白。
Disclaimer
除非我们的产品目录或产品附带的其他公司文档另有说明，否则我们的产品仅供研究使用，不得用于任何其他目的，包括但不限于未经授权的商业用途、体外诊断用途、离体或体内治疗用途或任何类型的消费或应用于人类或动物。
Immunogen
电泳纯化的人骨骼肌肌联蛋白。
Physical form
液体。含0.1％叠氮化钠。
未找到合适的产品？
试试我们的产品选型工具.
存储类别
12 - Non Combustible Liquids
wgk
nwg
flash_point_f
Not applicable
flash_point_c
Not applicable
Rafael De Cid et al.
Neurology, 85(24), 2126-2135 (2015-11-20)
To identify the genetic defects present in 3 families with muscular dystrophy, contractures, and calpain 3 deficiency. We performed targeted exome sequencing on one patient presenting a deficiency in calpain 3 on Western blot but for which mutations in the
Hong-Kee Tan et al.
Stem cells translational medicine, 3(5), 586-598 (2014-03-22)
Induced pluripotent stem cells (iPSCs) derived from somatic cells of patients can be a good model for studying human diseases and for future therapeutic regenerative medicine. Current initiatives to establish human iPSC (hiPSC) banking face challenges in recruiting large numbers
Michael Stauske et al.
Cells, 9(6) (2020-06-04)
Non-human primates (NHP) are important surrogate models for late preclinical development of advanced therapy medicinal products (ATMPs), including induced pluripotent stem cell (iPSC)-based therapies, which are also under development for heart failure repair. For effective heart repair by remuscularization, large
Stoyan Petkov et al.
Cells, 9(11) (2020-11-11)
Induced pluripotent stem cells (iPSCs) hold enormous potential for the development of cell-based therapies; however, the safety and efficacy of potential iPSC-based treatments need to be verified in relevant animal disease models before their application in the clinic. Here, we
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持